• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大儿童肺炎球菌疾病的流行病学和经济负担。

Epidemiological and economic burden of pneumococcal diseases in Canadian children.

作者信息

Petit Geneviève, De Wals Philippe, Law Barbara, Tam Theresa, Erickson Lonny James, Guay Maryse, Framarin Alicia

机构信息

Department of Community Health Sciences, University of Sherbrooke, Sherbrooke, Quebec.

出版信息

Can J Infect Dis. 2003 Jul;14(4):215-20. doi: 10.1155/2003/781794.

DOI:10.1155/2003/781794
PMID:18159460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2094937/
Abstract

BACKGROUND

With the arrival of a new conjugate pneumococcal vaccine, it is important to estimate the burden of pneumococcal diseases in Canadian children. The epidemiological data and the economic cost of these diseases are crucial elements in evaluating the relevance of a vaccination program.

METHODS

Using provincial databases, ad hoc surveys and published data, age-specific incidence rates of pneumococcal infections were estimated in a cohort of 340,000 children between six months and nine years of age. The costs of these diseases to the health system and to families were also evaluated using data from Quebec and Manitoba.

RESULTS

Cumulative risks were one in 5000 for pneumococcal meningitis, one in 500 for bacteremia and one in 20 for pneumonia, leading to 16 deaths in the cohort. About 262,000 otitis media episodes and 32,000 cases of myringotomy with ventilation tube insertion were attributable to Streptococcus pneumoniae. Societal costs were estimated at $125 million, of which 32% was borne by the health system and 68% was borne by families. Invasive infections represented only 2% of total costs, while 84% were generated by otitis media.

CONCLUSION

Pneumococcal infections represent a significant burden for Canadian children and society that could be significantly reduced through immunization.

摘要

背景

随着新型肺炎球菌结合疫苗的问世,估算加拿大儿童肺炎球菌疾病的负担变得至关重要。这些疾病的流行病学数据和经济成本是评估疫苗接种计划相关性的关键因素。

方法

利用省级数据库、专项调查和已发表的数据,对34万名6个月至9岁儿童队列中的肺炎球菌感染年龄别发病率进行了估算。还利用魁北克省和曼尼托巴省的数据评估了这些疾病给卫生系统和家庭带来的成本。

结果

肺炎球菌性脑膜炎的累积风险为5000分之一,菌血症为500分之一,肺炎为20分之一,该队列中有16人死亡。约26.2万例中耳炎发作和3.2万例鼓膜切开置管病例可归因于肺炎链球菌。社会成本估计为1.25亿加元,其中32%由卫生系统承担,68%由家庭承担。侵袭性感染仅占总成本的2%,而84%由中耳炎产生。

结论

肺炎球菌感染给加拿大儿童和社会带来了沉重负担,通过免疫接种可大幅减轻。

相似文献

1
Epidemiological and economic burden of pneumococcal diseases in Canadian children.加拿大儿童肺炎球菌疾病的流行病学和经济负担。
Can J Infect Dis. 2003 Jul;14(4):215-20. doi: 10.1155/2003/781794.
2
The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.在常规使用 7 价肺炎球菌结合疫苗之前加拿大人群中肺炎球菌病的负担。
Can J Infect Dis Med Microbiol. 2007 Mar;18(2):121-7. doi: 10.1155/2007/713576.
3
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children.健康婴幼儿接种肺炎球菌结合疫苗的预计成本效益
JAMA. 2000 Mar 15;283(11):1460-8. doi: 10.1001/jama.283.11.1460.
4
Pneumococcal conjugate vaccine for young children.用于幼儿的肺炎球菌结合疫苗。
Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim.
5
Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.评估在中国实施婴儿 13 价肺炎球菌结合疫苗国家免疫规划的成本效益。
PLoS One. 2018 Jul 25;13(7):e0201245. doi: 10.1371/journal.pone.0201245. eCollection 2018.
6
Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands.荷兰使用7价结合肺炎球菌疫苗进行普遍婴儿接种的流行病学影响及成本效益
Clin Ther. 2003 Oct;25(10):2614-30. doi: 10.1016/s0149-2918(03)80322-3.
7
A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.西班牙七价肺炎球菌结合疫苗的药物经济学评价
Value Health. 2004 Jan-Feb;7(1):36-51. doi: 10.1111/j.1524-4733.2004.71263.x.
8
Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.引入肺炎球菌结合疫苗后儿童复发性中耳炎及鼓膜置管插入次数的减少
Pediatrics. 2007 Apr;119(4):707-15. doi: 10.1542/peds.2006-2138.
9
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.5岁以下儿童肺炎链球菌所致疾病负担:全球估计数
Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6.
10
Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.
J Community Health. 2000 Feb;25(1):23-33. doi: 10.1023/a:1005136817158.

引用本文的文献

1
Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis.13价、15价和20价肺炎球菌结合疫苗在加拿大儿科人群中的比较:一项成本效用分析。
Can Commun Dis Rep. 2025 Feb 12;51(2-3):68-83. doi: 10.14745/ccdr.v51i23a02. eCollection 2025 Feb.
2
The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria.尼日利亚儿童临床肺炎和侵袭性肺炎球菌病的疾病负担。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007080.
3
Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia.澳大利亚肺炎球菌结合疫苗婴儿计划的回顾性影响分析及成本效益
Infect Dis Ther. 2021 Mar;10(1):507-520. doi: 10.1007/s40121-021-00409-7. Epub 2021 Feb 11.
4
Effects of Delayed Antibiotic Therapy on Outcomes in Children with Sepsis.延迟抗生素治疗对脓毒症儿童结局的影响。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00623-19. Print 2019 Sep.
5
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.加拿大13价肺炎球菌结合疫苗转为10价肺炎球菌结合疫苗用于婴儿接种的潜在临床和经济影响
Infect Dis Ther. 2018 Sep;7(3):353-371. doi: 10.1007/s40121-018-0206-1. Epub 2018 Jun 22.
6
Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies.非洲脑膜炎带1型肺炎链球菌负担:特定抗体功能的探索
Clin Vaccine Immunol. 2015 Apr;22(4):404-12. doi: 10.1128/CVI.00758-14. Epub 2015 Feb 4.
7
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.加拿大 13 价和 10 价肺炎球菌结合疫苗 2+1 剂量接种的成本效益。
BMC Infect Dis. 2012 Apr 24;12:101. doi: 10.1186/1471-2334-12-101.
8
Update on acute otitis media in children younger than 2 years of age.儿童急性中耳炎最新诊疗进展(年龄小于 2 岁)。
Can Fam Physician. 2011 Nov;57(11):1283-5.
9
The burden of pneumococcal disease in children less than 5 years of age in Abu Dhabi, United Arab Emirates.阿拉伯联合酋长国阿布扎比5岁以下儿童的肺炎球菌疾病负担。
Ann Saudi Med. 2011 Jul-Aug;31(4):356-9. doi: 10.4103/0256-4947.83214.
10
Burden of acute otitis media on Canadian families.加拿大家庭急性中耳炎负担。
Can Fam Physician. 2011 Jan;57(1):60-5.

本文引用的文献

1
Access to vaccines: A call to action.疫苗可及性:行动呼吁。
Can J Infect Dis. 2003 Jan;14(1):9-10. doi: 10.1155/2003/393841.
2
Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998.
Pediatr Infect Dis J. 2002 Oct;21(10):947-50. doi: 10.1097/00006454-200210000-00012.
3
Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada.
Pediatr Infect Dis J. 2002 Apr;21(4):348-50. doi: 10.1097/00006454-200204000-00018.
4
Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.
Can Commun Dis Rep. 2002 Apr 15;28(8):61-3.
5
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.肺炎球菌结合疫苗对急性中耳炎的疗效。
N Engl J Med. 2001 Feb 8;344(6):403-9. doi: 10.1056/NEJM200102083440602.
6
Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).预防婴幼儿肺炎球菌疾病。免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2000 Oct 6;49(RR-9):1-35.
7
Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome.儿科急诊科的隐匿性菌血症:当前患病率、检测时间及转归
Pediatrics. 2000 Sep;106(3):505-11. doi: 10.1542/peds.106.3.505.
8
Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
Clin Infect Dis. 2000 Jul;31(1):58-64. doi: 10.1086/313923. Epub 2000 Jul 24.
9
Etiology of community-acquired pneumonia in 254 hospitalized children.254名住院儿童社区获得性肺炎的病因
Pediatr Infect Dis J. 2000 Apr;19(4):293-8. doi: 10.1097/00006454-200004000-00006.
10
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.七价肺炎球菌结合疫苗在儿童中的有效性、安全性及免疫原性。北加利福尼亚凯撒医疗集团疫苗研究中心团队
Pediatr Infect Dis J. 2000 Mar;19(3):187-95. doi: 10.1097/00006454-200003000-00003.